Low expression of PINK1 and PARK2 predicts poor prognosis in patients with esophageal squamous cell carcinoma.

"Declarations Ethics approval and consent to participateThis research was approved by the Ethics Committee of the First Affiliated Hospital, Shihezi University School of Medicine (KJ2022-047-01), and written informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

"Funding This study was supported by the National Natural Science Foundation of China (82060513), the Bingtuan Science and Technology Program (2022ZD002), the Youth Program of Shihezi University (ZZZC202133) and the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2020-PT330-003)."